When was Microban founded?

Microban was founded in 1994 and raised its 1st funding round 5 years after it was founded.

Where is Microban located?

Microban is headquartered in Huntersville, United States.

How many employees does Microban have?

As of Sep 30, 2026, the latest employee count at Microban is 159.

Is Microban a funded company?

Microban is a funded company, having raised a total of $64.6M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 07, 1999.

When was the latest funding round of Microban?

Microban's latest funding was a $***** PE round on Feb 17, 2005, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.87B in funding in 2026 to date.

Where does Microban rank among its competitors?

Microban ranks 136th amongst 2038 active competitors, of which 449 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was One Biosciences, which secured $3.76M in Sep, 2026.

Who are the top competitors of Microban?

Microban's top competitors include Antheia, Synthego and Axol Bioscience. Among them, One Biosciences secured the most recent funding round in September, 2026.

Microban - 2026 Company Profile, Funding & Competitors

Company Details

Antimicrobial and odor control technologies for durable product protection and freshness. They are a global leader providing antimicrobial and odor control solutions to enhance products across diverse industries. They offer a comprehensive portfolio of antimicrobial technologies, odor capture solutions, and water-repellent coatings designed to improve product durability, cleanliness, and market success. Their technologies are integrated into materials like ceramics, coatings, foam, paper, plastics, and textiles, serving sectors such as automotive, building materials, consumer goods, food service, and healthcare. They focus on innovation, testing services, and partnerships to deliver cutting-edge solutions. They provide ingredient branding, offering a competitive edge and peace of mind to end-users. They are committed to sustainability and offer resources like blogs, FAQs, videos, and whitepapers to educate and support their partners.

Website: www.microban.com
Social

Key Metrics

Founded Year

1994

Location

Huntersville, United States

Stage

Acquired

Total Funding

$64.6M in 2 rounds

Latest Funding Round

PE, Feb 17, 2005, $*****

Investors

TA Associates & 2 more

Ranked

136^th among 2038 active competitors

Employee Count

159 as on Sep 30, 2026

Similar Companies

Antheia & 2744 more

Exit Details

Acquired by WMBarr (Dec 30, 2011)

View Microban's full profile

Microban got acquired by WMBarr on Dec 30, 2011.

Click here to take a look at Microban's acquisition in detail

Microban has raised a total funding of $64.6M over 2 rounds. Its first funding round was on Dec 07, 1999. Its latest funding round was a PE round on Feb 17, 2005 for $*****. 1 investor participated in its latest round. Microban has 3 institutional investors.

Here is the list of recent funding rounds of Microban:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 17, 2005	2083919	PE	1543708	4897163	1614499	6150968
Dec 07, 1999	5476344	Series A	1941489	2000045	4571255	UBS

Access funding benchmarks and valuations. Sign up today!

View details of Microban's funding rounds and investors

Microban's employee count trend

Microban has 159 employees as of Sep 26. Here is Microban's employee count trend over the years:

Uncover Microban's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Microban include Antheia, Synthego and Axol Bioscience. Here is the list of Top 10 competitors of Microban, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	68/100
2nd	Synthego 2012, Redwood City (United States), Acquired	Manufacturer of custom CRISPR gene editors and molecular biology reagents	$460M	8VC, Perceptive Advisors & 31 others	67/100
3rd	Axol Bioscience 2013, Cambridge (United Kingdom), Series A	Provider of human cells, reagents, and reprogramming services	$13.3M	Calculus Capital, Scottish Enterprise & 13 others	65/100
4th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
5th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 15 others	65/100
6th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	64/100
7th	Avalyn Pharma 2011, Seattle (United States), Public	Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis	$389M	Perceptive Advisors, Norwest & 22 others	64/100
8th	enGene 1999, Saint laurent (Canada), Public	Developer of oral non-viral gene therapy platform	$54M	Hercules Capital, Lumira Ventures & 15 others	63/100
9th	Watchmaker Genomics 2018, Boulder (United States), Series A	Developer of gene-editing technology	$48.3M	Decheng Capital, Eclipse	63/100
10th	One Biosciences 2020, Paris (France), Series A	Developer of single-cell therapeutics solutions to treat multiple health disorders	$22.4M	BLAST Premier, Redmile Group & 7 others	63/100
136th	Microban 1994, Huntersville (United States), Acquired	Antimicrobial and odor control technologies for durable product protection and freshness	$64.6M	TA Associates, UBS & 1 others	47/100